Sign in
MDT-MEDTRONIC PLC

Medtronic Secures Medicare Approval for Hypertension Device While Facing Lawsuits Over Patent Infringements and Racial Disparities in Pulse Oximeter Accuracy

Member Only Article

Saturday

16 November, 2024

Medtronic is making strides in hypertension treatment with Medicare approval for its Symplicity Spyral device, but it faces legal challenges over patent infringements. As the company gears up for earnings reports, can it navigate these hurdles while maintaining its growth trajectory in a competitive market?

article image for MDT

Article Impact Score

0
50
100
Under­perform
Bear­ish
Neu­tral
Bull­ish
Out­perform
0
Key Takeaways
  • Loading...
More on MEDTRONIC PLC
Read more insights on MEDTRONIC PLC

Most Read

Join Foliko Premium!

Unlock the entire library of Foliko's Generative AI Investment Research. Plus, get AI powered trading signals and stock price predictions.

Go Premium - 7 Day Free Trial
home-footer-logo

Any content provided on our website is for information purposes only. We do not provide investment advice, nor do we consider ourselves a financial institution. Seek a duly licensed professional for investment advice.